Skip to content

CAPRICOR THERAPEUTICS, INC.: 10-Q filed 2017-11-14

What CAPRICOR THERAPEUTICS, INC. reported in its quarterly report filed 2017-11-14 (fiscal Q3 2017): 35 published measures, 93 facts as tagged in accession 0001144204-17-058512.

This filing

Form
10-Q (quarterly report)
Filed
2017-11-14
Fiscal period
fiscal Q3 2017
Accession
0001144204-17-058512 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CAPRICOR THERAPEUTICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2017-09-3015,793,539USD
At 2016-12-3118,747,355USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2017-09-3020,064,313USD
At 2016-12-3122,750,509USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2017-09-30-4,270,774USD
At 2016-12-31-4,003,154USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2017-09-308,897,087USD
At 2016-12-313,204,378USD
At 2016-09-3018,020,875USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2017-07-01 to 2017-09-30-2,734,993USD92
2017-01-01 to 2017-09-30-9,873,748USD273
2016-07-01 to 2016-09-30-5,333,413USD92
2016-01-01 to 2016-09-30-14,288,602USD274

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2017-01-01 to 2017-09-30-11,563,582USD273
2016-01-01 to 2016-09-30-10,976,420USD274

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2017-01-01 to 2017-09-3032,185USD273
2016-01-01 to 2016-09-3086,422USD274

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2017-07-01 to 2017-09-30313,271USD92
2017-01-01 to 2017-09-302,190,541USD273
2016-07-01 to 2016-09-30746,781USD92
2016-01-01 to 2016-09-303,091,688USD274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2017-01-01 to 2017-09-308,553,697USD273
2016-01-01 to 2016-09-3018,628,792USD274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2017-01-01 to 2017-09-307,965,544USD273
2016-01-01 to 2016-09-305,402,382USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2017-09-30-63,852,990USD
At 2016-12-31-53,979,242USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2017-09-30394,031USD
At 2016-12-31435,336USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2017-07-01 to 2017-09-30427,482USD92
2017-01-01 to 2017-09-301,297,362USD273
2016-07-01 to 2016-09-30554,566USD92
2016-01-01 to 2016-09-301,499,177USD274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2017-07-01 to 2017-09-30-2,637,733USD92
2017-01-01 to 2017-09-30-9,581,974USD273
2016-07-01 to 2016-09-30-5,240,074USD92
2016-01-01 to 2016-09-30-14,063,189USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2017-09-3015,232,420USD
At 2016-12-3118,108,340USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2017-07-01 to 2017-09-30107,653USD92
2017-01-01 to 2017-09-30318,500USD273
2016-07-01 to 2016-09-3098,749USD92
2016-01-01 to 2016-09-30241,760USD274

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2017-09-3016,688,054USD
At 2016-12-314,895,183USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2017-09-30105,692USD
At 2016-12-31142,253USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2017-07-01 to 2017-09-302,951,004USD92
2017-01-01 to 2017-09-3011,772,515USD273
2016-07-01 to 2016-09-305,986,855USD92
2016-01-01 to 2016-09-3017,154,877USD274

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2017-07-01 to 2017-09-301,862,369USD92
2017-01-01 to 2017-09-308,247,700USD273
2016-07-01 to 2016-09-304,727,111USD92
2016-01-01 to 2016-09-3013,376,178USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2017-09-3025,100,388shares
At 2016-12-3121,399,019shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2017-09-309,507,262USD
At 2016-12-314,551,603USD
At 2016-09-3018,623,060USD
At 2015-12-315,568,306USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2017-09-308,593USD
At 2016-12-313,524USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2017-09-30713,746USD
At 2016-12-31686,013USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2017-09-30319,715USD
At 2016-12-31250,677USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2017-09-30190,278USD
At 2016-12-31342,892USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2017-07-01 to 2017-09-30-2,733,717USD92
2017-01-01 to 2017-09-30-9,868,679USD273
2016-07-01 to 2016-09-30-5,337,268USD92
2016-01-01 to 2016-09-30-14,297,064USD274

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2017-07-01 to 2017-09-301,088,635USD92
2017-01-01 to 2017-09-303,524,815USD273
2016-07-01 to 2016-09-301,259,744USD92
2016-01-01 to 2016-09-303,778,699USD274

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2017-01-01 to 2017-09-3073,034USD273
2016-01-01 to 2016-09-3063,218USD274

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2017-01-01 to 2017-09-30109,595USD273
2016-01-01 to 2016-09-3091,812USD274

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2017-01-01 to 2017-09-3036,562USD273
2016-01-01 to 2016-09-3036,562USD274

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2017-07-01 to 2017-09-30-97,260USD92
2017-01-01 to 2017-09-30-291,774USD273
2016-07-01 to 2016-09-30-93,339USD92
2016-01-01 to 2016-09-30-225,413USD274

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2017-01-01 to 2017-09-300USD273
2016-01-01 to 2016-09-301,343USD274

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2017-01-01 to 2017-09-300USD273
2016-01-01 to 2016-09-300USD274

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2017-01-01 to 2017-09-308,303,697USD273
2016-01-01 to 2016-09-3013,864,817USD274

Inspect the source

Entity
CAPRICOR THERAPEUTICS, INC. / CIK 0001133869
Captured
2026-09-20T07:41:24.575Z
SEC response SHA-256
b9f947143784aa2a5b7cc0470638338f21bd5664475f1be49c554014f98dbf5c

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001133869.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))